Akari Therapeutics Receives Positive and Constructive Pre-Ind Feedback From US FDA for Pas-Nomacopan in Treatment of Geographic Atrophy
akari therapeutics收到美國FDA關於Pas-Nomacopan在治療地理性萎縮症方面的積極和建設性的Pre-Ind反饋
Akari Therapeutics Receives Positive and Constructive Pre-Ind Feedback From US FDA for Pas-Nomacopan in Treatment of Geographic Atrophy
akari therapeutics收到美國FDA關於Pas-Nomacopan在治療地理性萎縮症方面的積極和建設性的Pre-Ind反饋
譯文內容由第三人軟體翻譯。